{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T21:05:05Z","timestamp":1771621505082,"version":"3.50.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1995,3,1]],"date-time":"1995-03-01T00:00:00Z","timestamp":794016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,29]],"date-time":"2016-12-29T00:00:00Z","timestamp":1482969600000},"content-version":"vor","delay-in-days":7974,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[1995,3]]},"DOI":"10.1378\/chest.107.3.817","type":"journal-article","created":{"date-parts":[[2008,1,22]],"date-time":"2008-01-22T22:31:17Z","timestamp":1201041077000},"page":"817-825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Alternative Pharmacotherapies for Steroid-Dependent Asthma"],"prefix":"10.1016","volume":"107","author":[{"given":"Richard B.","family":"Moss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.107.3.817_bib1","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0091-6749(73)90062-6","article-title":"An approach to the use of immunosuppressive drugs in nonmalignant disease","volume":"52","author":"Steinberg","year":"1973","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.107.3.817_bib2","first-page":"762","article-title":"Methotrexate for the treatment of chronic steroid-dependent asthma","volume":"12","author":"Reid","year":"1993","journal-title":"Clin Pharm"},{"issue":"suppl B","key":"10.1378\/chest.107.3.817_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0954-6111(06)80357-4","article-title":"Methotrexate in the treatment of severe asthma","volume":"87","author":"Yntema","year":"1993","journal-title":"Respir Med"},{"key":"10.1378\/chest.107.3.817_bib4","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1365-2222.1991.tb00844.x","article-title":"Methotrexate in asthma","volume":"21","author":"Geddes","year":"1991","journal-title":"Clin Exp Allergy"},{"key":"10.1378\/chest.107.3.817_bib5","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0091-6749(91)90339-P","article-title":"Methotrexate in bronchial asthma","volume":"88","author":"Calderon","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.107.3.817_bib6","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJM198803103181004","article-title":"Methotrexate in the treatment of corticosteroid-dependent asthma","volume":"318","author":"Mullarkey","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.107.3.817_bib7","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/0003-4819-112-8-577","article-title":"Long-term methotrexate treatment in corticosteroid-dependent asthma","volume":"112","author":"Mullarkey","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.107.3.817_bib8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0140-6736(90)91659-X","article-title":"Randomised, double-blind, placebo-controlled trial of methotrexate in steroid-dependent asthma","volume":"336","author":"Shiner","year":"1990","journal-title":"Lancet"},{"key":"10.1378\/chest.107.3.817_bib9","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0091-6749(91)90330-Q","article-title":"Methotrexate in the treatment of steroid-dependent asthma","volume":"88","author":"Dyer","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.107.3.817_bib10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.7326\/0003-4819-114-5-353","article-title":"Lack of benefit of methotrexate in severe, steroid-dependent asthma","volume":"114","author":"Erzurum","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.107.3.817_bib11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0954-6111(93)90094-G","article-title":"Comparison of methotrexate 30 mg per week with placebo in chronic steroid-dependent asthma: a 12-week double-blind cross-over study","volume":"87","author":"Trigg","year":"1993","journal-title":"Respir Med"},{"key":"10.1378\/chest.107.3.817_bib12","first-page":"409","article-title":"Methotrexate in the management of severe steroid dependent asthma","volume":"106","author":"Taylor","year":"1993","journal-title":"NZ Med J"},{"key":"10.1378\/chest.107.3.817_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1378\/chest.105.1.117","article-title":"The role of methotrexate in the management of steroid-dependent asthma","volume":"105","author":"Coffey","year":"1994","journal-title":"Chest"},{"key":"10.1378\/chest.107.3.817_bib14","first-page":"541","article-title":"Methotrexate for asthma: a critical appraisal","volume":"62","author":"Kaslow","year":"1989","journal-title":"Ann Allergy"},{"key":"10.1378\/chest.107.3.817_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1164\/ajrccm\/143.1.179","article-title":"Methotrexate-induced asthma","volume":"143","author":"Jones","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.107.3.817_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1164\/ajrccm\/143.1.1","article-title":"Methotrexate: does it treat or induce asthma?","volume":"143","author":"Fertel","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.107.3.817_bib17","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1056\/NEJM198803103181010","article-title":"Steroids and \u2018steroid-sparing\u2019 agents in asthma","volume":"318","author":"Cott","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.107.3.817_bib18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000236426","article-title":"Methotrexate pneumonitis in bronchial asthma","volume":"100","author":"Tsai","year":"1993","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1378\/chest.107.3.817_bib19","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/0140-6736(92)91325-3","article-title":"Fatal Pneumocystis pneumonia in asthmatic patient treated with methotrexate","volume":"339","author":"Vallerand","year":"1992","journal-title":"Lancet"},{"key":"10.1378\/chest.107.3.817_bib20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0091-6749(91)90326-J","article-title":"Effect of low-dose methotrexate on the disposition of glucorticoids and theophylline","volume":"88","author":"Glynn-Barnhart","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.107.3.817_bib21","first-page":"346","article-title":"Use of methotrexate in the treatment of steroid-dependent adolescent asthmatics","volume":"67","author":"Stempel","year":"1991","journal-title":"Ann Allergy"},{"key":"10.1378\/chest.107.3.817_bib22","first-page":"635","article-title":"Methotrexate treatment for severe asthma in children","volume":"89","author":"Guss","year":"1992","journal-title":"Pediatrics"},{"key":"10.1378\/chest.107.3.817_bib23","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0091-6749(74)90027-X","article-title":"Troleandomycin: effectiveness in steroid-dependent asthma and bronchitis","volume":"54","author":"Spector","year":"1974","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.107.3.817_bib24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0091-6749(80)90004-4","article-title":"The effect of troleandomycin on methylprednisolone elimination","volume":"66","author":"Szefler","year":"1980","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.107.3.817_bib25","first-page":"37","article-title":"Effect of low-dose troleandomycin on glucocorticoid pharmacokinetics and airway hyperresponsiveness in severely asthmatic children","volume":"65","author":"Ball","year":"1990","journal-title":"Ann Allergy"},{"key":"10.1378\/chest.107.3.817_bib26","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0091-6749(93)90345-G","article-title":"Efficacy and safety of low-dose troleandomycin therapy in children with severe, steroid-requiring asthma","volume":"91","author":"Kamada","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.107.3.817_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0091-6749(78)90088-X","article-title":"Enhancement by oleandomycin of the inhibitory effect of methylprednisolone on phytohemagglutinin-stimulated lymphocytes","volume":"62","author":"Ong","year":"1978","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.107.3.817_bib28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1164\/ajrccm\/141.1.72","article-title":"Erythromycin inhibits respiratory glyconjugate secretion from human airways in vitro","volume":"141","author":"Goswami","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.107.3.817_bib29","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1378\/chest.99.3.670","article-title":"Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma","volume":"99","author":"Miyatake","year":"1991","journal-title":"Chest"},{"key":"10.1378\/chest.107.3.817_bib30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0091-6749(86)90112-0","article-title":"An improved protocol for the use of troleandomycin in the treatment of steroid-requiring asthma","volume":"78","author":"Wald","year":"1986","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.107.3.817_bib31","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1164\/ajrccm\/147.2.398","article-title":"A double-blind study of troleandomycin and methylprednisolone in asthmatic subjects who require daily corticosteroids","volume":"147","author":"Nelson","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.107.3.817_bib32","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/0091-6749(80)90003-2","article-title":"Efficacy of troleandomycin in outpatients with severe, corticosteroid-dependent asthma","volume":"66","author":"Zieger","year":"1980","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.107.3.817_bib33","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0091-6749(93)90010-D","article-title":"Troleandomycin in the treatment of difficult asthma","volume":"92","author":"Siracusa","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.107.3.817_bib34","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/ppul.1950100308","article-title":"Benefits and complications of troleandomycin in young children with steroid-dependent asthma","volume":"10","author":"Flotte","year":"1991","journal-title":"Pediatr Pulmonol"},{"key":"10.1378\/chest.107.3.817_bib35","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0167-5699(93)90048-P","article-title":"FK506 and cyclosporin, molecular probes for studying intracellular signal tranduction","volume":"14","author":"Liu","year":"1993","journal-title":"Immunol Today"},{"key":"10.1378\/chest.107.3.817_bib36","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0167-5699(92)90026-4","article-title":"T cells and eosinophils in the pathogenesis of asthma","volume":"13","author":"Corrigan","year":"1992","journal-title":"Immunol Today"},{"key":"10.1378\/chest.107.3.817_bib37","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0091-6749(92)90331-U","article-title":"Is there a role for cyclosporin in asthma?","volume":"89","author":"Calderon","year":"1992","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.107.3.817_bib38","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/0140-6736(92)91646-P","article-title":"Trial of cyclosporin in corticosteroid-dependent chronic severe asthma","volume":"339","author":"Alexander","year":"1992","journal-title":"Lancet"},{"key":"10.1378\/chest.107.3.817_bib39","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1183\/09031936.93.04030380","article-title":"Cyclosporin for a severe case of aspirin-induced asthma","volume":"4","author":"Nizankowska","year":"1991","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.107.3.817_bib40","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1398-9995.1991.tb00590.x","article-title":"Cyclosporin for steroid-dependent asthma","volume":"46","author":"Szczeklik","year":"1991","journal-title":"Allergy"},{"key":"10.1378\/chest.107.3.817_bib41","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0140-6736(92)90317-V","article-title":"Cyclosporin and asthma [letter]","volume":"339","author":"Szczeklik","year":"1992","journal-title":"Lancet"},{"key":"10.1378\/chest.107.3.817_bib42","first-page":"132","article-title":"Gold salt in the treatment of bronchial asthma\u2014a double-blind study","volume":"40","author":"Muranaka","year":"1978","journal-title":"Ann Allergy"},{"key":"10.1378\/chest.107.3.817_bib43","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0091-6749(88)90213-8","article-title":"An open study of auranofin in the treatment of steroid-dependent asthma","volume":"81","author":"Bernstein","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.107.3.817_bib44","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/thx.47.5.349","article-title":"Auranofin in the treatment of steroid dependent asthma: a double-blind study","volume":"47","author":"Nierop","year":"1992","journal-title":"Thorax"},{"key":"10.1378\/chest.107.3.817_bib45","first-page":"288","article-title":"Oral gold therapy in steroid-dependent asthma, nasal polyposis, and aspirin hypersensitivity","volume":"65","author":"McNeil","year":"1990","journal-title":"Ann Allergy"},{"key":"10.1378\/chest.107.3.817_bib46","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0022-3476(84)80073-6","article-title":"IgG subclasses in nonallergic children with chronic chest symptoms","volume":"105","author":"Smith","year":"1984","journal-title":"J Pediatr"},{"key":"10.1378\/chest.107.3.817_bib47","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1136\/adc.63.12.1434","article-title":"IgG subclass deficiency in asthma","volume":"63","author":"Loftus","year":"1988","journal-title":"Arch Dis Child"},{"key":"10.1378\/chest.107.3.817_bib48","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/S0090-1229(05)80040-6","article-title":"IgG subclass deficiency with or without IgA deficiency","volume":"61","author":"Hanson","year":"1991","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1378\/chest.107.3.817_bib49","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/08820139109050785","article-title":"IgG subclasses and antibody response to pneumococcal capsular polysaccharides in children with severe sinopulmonary infections and asthma","volume":"20","author":"Bernatowska-Matuskiewicz","year":"1991","journal-title":"Immunol Invest"},{"key":"10.1378\/chest.107.3.817_bib50","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/08820139109050787","article-title":"The pharmacokinetics of total IgG, IgG subclasses, and type specific antibodies in immunodeficient patients","volume":"20","author":"Lee","year":"1991","journal-title":"Immunol Invest"},{"key":"10.1378\/chest.107.3.817_bib51","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/0091-6749(91)90147-G","article-title":"Intravenous immunoglobulin: a new therapeutic approach in steroid-dependent asthma?","volume":"88","author":"Levinson","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.107.3.817_bib52","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-3476(88)80137-9","article-title":"Asthma and selective immunoglobulin subclass deficiency: improvement of asthma after immunoglobulin replacement therapy","volume":"112","author":"Page","year":"1988","journal-title":"J Pediatr"},{"key":"10.1378\/chest.107.3.817_bib53","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/0091-6749(91)90420-S","article-title":"An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma","volume":"87","author":"Mazer","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.107.3.817_bib54","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1398-9995.1994.tb00833.x","article-title":"Slight steroid-sparing effect of intravenous immunoglobulin in children and adolescents with moderately severe bronchial asthma","volume":"49","author":"Jakobsson","year":"1994","journal-title":"Allergy"},{"key":"10.1378\/chest.107.3.817_bib55","first-page":"53","article-title":"Open study of hydroxychloroquine in the treatment of severe symptomatic or corticosteroid-dependent asthma","volume":"65","author":"Charous","year":"1990","journal-title":"Ann Allergy"},{"key":"10.1378\/chest.107.3.817_bib56","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/0091-6749(91)90393-3","article-title":"The effect of dapsone in steroid-dependent asthma","volume":"87","author":"Berlow","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.1378\/chest.107.3.817_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0952-0600(92)90011-5","article-title":"Loop diuretics and asthma","volume":"5","author":"Chung","year":"1992","journal-title":"Pulm Pharmacol"},{"key":"10.1378\/chest.107.3.817_bib58","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1183\/09031936.93.06010130","article-title":"Inhaled loop diuretics as potential new anti-asthmatic drugs","volume":"6","author":"Bianco","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.107.3.817_bib59","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1001\/jama.1987.03390080066032","article-title":"Bronchodilating effect of intravenous magnesium sulfate in bronchial asthma","volume":"257","author":"Okayama","year":"1987","journal-title":"JAMA"},{"key":"10.1378\/chest.107.3.817_bib60","first-page":"388","article-title":"Acute effect of intravenous magnesium sulfate on airway obstruction of asthmatic patients","volume":"61","author":"Rolla","year":"1988","journal-title":"Ann Allergy"},{"key":"10.1378\/chest.107.3.817_bib61","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/jama.1989.03430090072036","article-title":"Intravenous magnesium sulfate for the treatment of acute asthma in the emergency department","volume":"262","author":"Skobeloff","year":"1989","journal-title":"JAMA"},{"key":"10.1378\/chest.107.3.817_bib62","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1378\/chest.97.2.373","article-title":"Bronchodilating effect of intravenous magnesium sulfate in acute severe bronchial asthma","volume":"97","author":"Noppen","year":"1990","journal-title":"Chest"},{"key":"10.1378\/chest.107.3.817_bib63","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0196-0644(05)80653-5","article-title":"A trial of nebulized magnesium sulfate to reverse bronchospasm in asthmatic patients","volume":"21","author":"Chande","year":"1992","journal-title":"Ann Emerg Med"},{"key":"10.1378\/chest.107.3.817_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0735-6757(92)90114-D","article-title":"Serum magnesium levels in asthmatic patients during acute exacerbations of asthma","volume":"10","author":"Falkner","year":"1992","journal-title":"Am J Emerg Med"},{"key":"10.1378\/chest.107.3.817_bib65","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0196-0644(05)81898-0","article-title":"Frequently nebulized beta-agonists for asthma: effects on serum electrolytes","volume":"21","author":"Bodenhamer","year":"1992","journal-title":"Ann Emerg Med"},{"key":"10.1378\/chest.107.3.817_bib66","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1378\/chest.105.3.701","article-title":"Magnesium sulfate potentiates several cardiovascular and metabolic actions of terbutaline","volume":"105","author":"Skorodin","year":"1994","journal-title":"Chest"},{"key":"10.1378\/chest.107.3.817_bib67","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0196-0644(05)80885-6","article-title":"Intravenous magnesium for acute asthma: failure to decrease emergency treatment duration or need for hospitalization","volume":"21","author":"Green","year":"1992","journal-title":"Ann Emerg Med"},{"key":"10.1378\/chest.107.3.817_bib68","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1378\/chest.104.3.831","article-title":"Magnesium bolus or infusion fails to improve expiratory flow in acute asthma exacerbations","volume":"104","author":"Tiffany","year":"1993","journal-title":"Chest"},{"key":"10.1378\/chest.107.3.817_bib69","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0735-6757(94)90238-0","article-title":"Rapid infusion of magnesium sulfate obviates need for intubation in status asthmaticus","volume":"12","author":"Schiermeyer","year":"1994","journal-title":"Am J Emerg Med"},{"key":"10.1378\/chest.107.3.817_bib70","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/02770909209059877","article-title":"Alternative treatments for asthma: assessing the need","volume":"29","author":"Szefler","year":"1992","journal-title":"J Asthma"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215445465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215445465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T01:56:40Z","timestamp":1680227800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215445465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,3]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,3]]}},"alternative-id":["S0012369215445465"],"URL":"https:\/\/doi.org\/10.1378\/chest.107.3.817","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[1995,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alternative Pharmacotherapies for Steroid-Dependent Asthma","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.107.3.817","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1995 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}